3Miller MJ, Carter DE, Sipes IG. Pharmaeokineties of acrylamide in Fisher-344 rats [J]. Toxicol Appl Pharmacot, 1982,63:36-44.
4Bull PJ, Brooke RK, Cocker J, et al. An occupational hygiene investigation of exposure to acrylamide and the role for urinary S-carboxyethyl-cysteine (CEC) as a biological marker[J]. Ann Occup Hyg, 2005,1:234-236.
5Gold BG, Voda J, Yu X, et al. The inununosuppressant FK506 elicits a neuronal heat shock response and protects against acrylamide neuropathy [ J]. Exp Neurol, 2004, 187: 160-170.
6LoPachin RM, Ross JF, Reid ML, et al. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5- hexanedione[J]. Neurotoxicology, 2002, 23:95-110.
7Fansa H, Keilhoff G, Horn T, et al. Stimulation of Schwann cell proliferation and axonal regeneration by FKS06 [ J ]. Res Neurol Neuro, 2000: 16-77.
8Kaplan M, Murphy SD. Effect of acrylamide on rotarod performance and sciatic nerve-glucuronidase activity of rats[J]. Toxicol Appl Pharmacol, 1972,22:259-268.
9Bavetta S, Hamlyn PJ, Bumstock G, et al. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration [ J ]. Exp Neurol, 1999,158:382-393.
10Udina E, Ceballos D, Gold BG, et al. FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers[J]. Exp Neurol, 2003,183:220-231.
